IP Library Granted Patent US 7,943,293
Granted Patent B2
US 7,943,293 · App. 12/454,942 · Granted May 17, 2011

Media solutions and methods for cryopreservation and thawing of in vitro fertilization specimens

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,943,293
App. No.
12/454,942
Granted
May 17, 2011
Kind
B2
Abstract

A medium solution which will increase the growth, survival and ultimately the live birth rate of oocytes and embryos which have been or will be subjected to cryopreservation. The solution contains varied amounts of glucose, pyruvates, amino acids, vitamins K5 and C, antioxidants, fatty acids to supply the specimens with the chemical ingredients and uptake requirements required to recover and prosper during and after the cryopreservation process. The solution supplies nutrients to the specimens that will replenish depletion and damage to the specimens and their mitochondria, spindles and structural features, such as cell walls. One formulation addresses the additional requirements of frozen specimens as opposed to the current media solutions and methods which treat the un-frozen specimens the same as the frozen specimens when recovering them from cryopreservation.

Claims (15)

1. A method of freezing or vitrifying an embryo or oocyte specimen or specimens for storage in liquid nitrogen, said method comprising;

a) removing said specimen or specimens from a culture medium and placing said specimen or specimens in a first rejuvenation medium comprising effective amounts of glucose, pyruvate, amino acids, vitamins K5 and C, antioxidants, and fatty acids sufficient to supply the specimen or specimens with chemical ingredients and uptake requirements required to recover and prosper during the cryopreservation process, said first rejuvenation medium being operative to supply nutrients which will protect from depletion and damage to said specimen or specimens and its or their mitochondria, spindles, and structural features during cryopreservation, said first rejuvenation medium being devoid of HEPES or MOPS;

b) removing said specimen or specimens from said first rejuvenation medium and placing said specimen or specimens into a second rejuvenation medium comprising effective amounts of glucose, pyruvate, amino acids, vitamins K5 and C, antioxidants, and fatty acids sufficient to supply the specimen or specimens with chemical ingredients and uptake requirements required to recover and prosper during the cryopreservation process, said second rejuvenation medium being operative to supply nutrients which will protect from depletion and damage to said specimen or specimens and its or their mitochondria, spindles, and structural features during cryopreservation, said second rejuvenation medium including HEPES or MOPS;

c) removing said specimen or specimens from said second rejuvenation medium and placing said specimen or specimens in a first solution comprising a first amount of one or more cryoprotectants;

d) removing said specimen or specimens from said first solution and placing said specimen or specimens in a second solution comprising a second amount of one or more cryoprotectants which is greater than said first amount of cryoprotectant in step c); and

e) removing said specimen or specimens from said second solution and placing said specimen or specimens in liquid nitrogen.

2. The method of claim 1 , wherein said fatty acids include lipoic acid and linoleic acid.

3. The method of claim 2 , wherein said lipoic acid is present in a concentration range of about 0.000004 g/L to about 0.000008 g/L.

4. The method of claim 2 , wherein said linoleic acid is present in a concentration range of about 0.0000025 g/L to about 0.000010 g/L.

5. A method of freezing or vitrifying an embryo or oocyte specimen for storage in liquid nitrogen, said method comprising;

a) removing said specimen from a culture medium and placing said specimen in a first rejuvenation medium comprising effective amounts of glucose, pyruvate, amino acids, vitamins K and C, antioxidants, and fatty acids sufficient to supply the specimen with chemical ingredients and uptake requirements required to recover and prosper during the cryopreservation process, said first rejuvenation medium being operative to supply nutrients which will protect from depletion and damage to said specimen and its mitochondria, spindles, and structural features during cryopreservation, said first rejuvenation medium being devoid of HEPES or MOPS;

b) removing said specimen from said first rejuvenation medium and placing said specimen into a second rejuvenation medium comprising effective amounts of glucose, pyruvate, amino acids, vitamins K and C, antioxidants, and fatty acids sufficient to supply the specimen with chemical ingredients and uptake requirements required to recover and prosper during the cryopreservation process, said second rejuvenation medium being operative to supply nutrients which will protect from depletion and damage to said specimen and its mitochondria, spindles, and structural features during cryopreservation, said second rejuvenation medium including HEPES or MOPS;

c) removing said specimen from said second rejuvenation medium and placing said specimen in a first solution comprising a first amount of one or more cryoprotectants;

d) removing said specimen from said first solution and placing said specimen in a second solution comprising a second amount of one or more cryoprotectants which is greater than said first amount of cryoprotectant in step c); and

e) removing said specimen from said second solution and placing said specimen in liquid nitrogen.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2018
From: LIFEGLOBAL GROUP, LLC; LIFEGLOBAL, INC.; LIFEGLOBAL EUROPE, SPRL; LIFEGLOBAL GROUP ASIA LIMITED; EVOLVEGENE, LLC; EVOLVEGENE, INC.
To: COOPERSURGICAL, INC.
Reel/Frame 046983/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2018
From: LIFEGLOBAL GROUP, LLC; LIFEGLOBAL, INC.; LIFEGLOBAL EUROPE, SPRL; LIFEGLOBAL GROUP ASIA LIMITED; EVOLVEGENE, LLC; EVOLVEGENE, INC.
To: COOPERSURGICAL, INC.
Reel/Frame 047248/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2018
From: LIFEGLOBAL GROUP, LLC F/K/A LIFEGLOBAL, LLC
To: LIFEGLOBAL GROUP, LLC F/K/A IVFONLINE.COM, LLC
Reel/Frame 045052/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2018
From: GENX INTERNATIONAL, INC.
To: IVFONLINE, LLC [PROPERLY IVFONLINE.COM, LLC]
Reel/Frame 045456/0717 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2018
From: IVFONLINE.COM, LLC
To: LIFEGLOBAL GROUP, LLC F/K/A LIFEGLOBAL, LLC
Reel/Frame 045047/0537 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2013
From: IVFONLINE.COM, LLC
To: LIFEGLOBAL GROUP, LLC
Reel/Frame 031485/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2013
From: GENX INTERNATIONAL, INC.
To: IVFONLINE LLC, DBA LIFEGLOBAL
Reel/Frame 031306/0408 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2009
From: CECCHI, MICHAEL D.
To: GENX INTERNATIONAL, INC.
Reel/Frame 022796/0437 →